Life Sciences Tools & Services
Price
$72.43
-0.03%Market Cap
$11.36B
Day High
$72.48
Day Low
$72.40
Bio-Techne agreed to be acquired by Merck KGaA for $73.00 per share in cash while FY2026 results showed flat revenue, a reported earnings surge from prior-year charges, and a 1% decline in adjusted net earnings.
Key risk: International operations and geopolitical exposure
Approximately 48% of fiscal 2026 sales came from outside the U.S., with expansion planned in China, India and other developing markets; military conflicts and trade tensions, including Russia's invasion of Ukraine, could disrupt operations and increase compliance costs.
Other Life Sciences Tools & Services companies